-
Godzilla Minus Zero Review: Takashi Yamazaki’s Anti-Nuclear Allegory
-
Euro-Area Growth Slows to 0.4% While Employment Stalls
-
DA Demands No-Work-No-Pay for Striking Municipal Workers in Coalition Talks
-
UK Economy Grows 0.7% in Third Quarter as Services Lead Expansion
-
US Wholesale Inflation Eases Monthly but Hits a Four-Year Annual High
-
India's Retail Inflation Reaches 6.09% as Food Prices Accelerate
-
India's Wholesale Inflation Jumps to 12.29% as Fuel Costs Surge
-
Malta Emerges as Premier Low-Season Destination for UK Travelers
-
China's October Activity Data Reveal a Weak Start to the Fourth Quarter
-
Japan's Economy Edges Into Contraction as Costly Oil Weighs on Demand
-
Philippines Urges ASEAN and China to Accelerate South China Sea Code of Conduct
-
UK Home Asking Prices Drop £6,745 in November Amid High Mortgage Rates
-
Mbeki Claims No Progress Since 2018; Author Cites Infrastructure and Economic Gains
-
Alex Georgiev Sets Personal Record to Win NCAA Pole Vault at Penn Relays
-
Qatar's Amir and Venezuelan Acting President Discuss Energy Cooperation
-
SMX Brings a New Level of Transparency to Gold Trading Through trueGold Technology
-
GameSquare Holdings Reports 2026 Third Quarter Results with Revenue up 77% YoY and Net Income Reaches $10.1 Million
-
ValorPay UAB Goes Live on T2, the Eurosystem's Real-Time Settlement System
-
CNS Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Progress in Establishing Transformative Therapeutic Pipeline
-
XCF Global Reports Third Quarter 2026 Financial Results & Affirms 2027 Outlook
-
NuRAN Wireless Eliminates Floating-Price Preferred Overhang and Locks In a Fixed C$1.20 Conversion Price
-
NextSource Materials Appoints Eugene Lee as Chief Financial Officer
-
International Battery Metals Ltd. Reports Second Quarter of Fiscal Year 2027 Financial Results
-
Abasca Resources Engages Northern Arc Public Affairs to Advance Federal Engagement on the Loki Flake Graphite Project
-
AsiaFIN Holdings Corp. Announces Third Quarter 2026 Results, Reporting Strong Nine-Month Financial Performance with Improved Margins
-
Thalia Therapeutics PLC Announces Promising Interim Phase I Data for miRisten in AML
-
Strategic Metals Reports Promising Results From the Rusty and Ranch Projects
-
Golden Minerals Reports Third Quarter 2026 Financial Results
-
OBI Pharma Signs Collaboration and License Agreement with Novartis
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 16
-
Blue Chip Capital Group Announces Quotation of its Common Stock on the OTCID and Updates Status of Initial Regulatory Compliance
-
Cardiff Lexington Announces Third Quarter 2026 Financial Results
-
Emerging Growth Research Highlights Criticality of First Phosphate G7-Backed LFP Battery Onshoring Solution as Cleantech Sector Accelerates Post U.S. Midterms
-
Presidio Property Trust, Inc. Announces Earnings for the Quarter Ended September 30, 2026
-
Sekur Private Data Ltd. Provides Update on Expected Closing of Non-Brokered Private Placement
-
iFabric Corp Announces Record Revenues for Q3 2026 and the Nine Months Ended September 30, 2026
-
RenX Enterprises Reports Record Third Quarter Revenue of $4.49 Million, Up 27.6% Year Over Year
-
Aptevo Provides 3Q26 Business Update Highlighting Growing Momentum for Mipletamig and Reports Third Quarter Financial Results
-
Gladstone Capital Corporation Earnings Call and Webcast Information
-
Sharecare Partners With HomeTown Health to Bring AskMD, Funded Through the GREAT Health Program, to More Rural Hospitals and Patients Across Georgia
-
Wi2Wi Reports 35% Revenue Growth to US$2.36M and Returns to Profitability with US$268K Net Income in Q3 2026
-
Ainos Reports Third Quarter 2026 Results and Highlights Expanding AI Nose Commercial Momentum
-
Westell Technologies, Inc. Announces Its Commencing a Tender Offer
-
Rescue Intellitech Expands Professional Decontamination Portfolio for Fire Departments with DeconWasher(TM) Pro S
-
MicroVision Lidar Powers Commercial Driverless Trucking at Scale with Kodiak AI
-
Expecting a Refund but Owe Back Taxes? Clear Start Tax Explains How the IRS Offset Program Takes It First
-
SMX: The Future of Gold Will Be Defined by What We Know About It -Powering Verified Trade and Tokenisation
-
Hawai‘i Falls to North Dakota State, Bowl Hopes Dashed
-
Big Mamma Founder Tigrane Seydoux Brings Italian Restaurant Group to Florida
-
Park Jin-young Denies Cult Allegations Against Firstfruits Group
DEA's Last MARIJUANA Gamble: Unconstitutional ALJ System Collapses as MMJ BioPharma Fights Back
This is more than a marijuana case. It's a constitutional case. It's a test of whether the DEA is still accountable to the courts, to the people, and to the law.
"If the DEA believes it can ignore the Supreme Court, then no American is safe from administrative tyranny," Duane Boise warned. " MMJ will fight. And we will win."
WASHINGTON, D.C. / ACCESS Newswire / June 24, 2025 / The U.S. Drug Enforcement Administration (DEA) has doubled down on an administrative law judge (ALJ) system the Supreme Court has already deemed unconstitutional and which the Department of Justice (DOJ) itself now refuses to defend. At the center of this constitutional implosion is MMJ BioPharma Cultivation, a federally compliant pharmaceutical cannabis company fighting a multi front legal war against regulatory sabotage.

Despite having earned FDA orphan drug designation and submitting multiple Investigational New Drug (IND) applications, MMJ has spent over 2,380 days awaiting DEA registration to Cultivate Schedule I pharmaceutical grade marijuana for use in clinical trials targeting Multiple Sclerosis and Huntington's Disease.
Instead of progress, MMJ faces a DEA rogue tribunal and a broken justice mechanism that the Supreme Court and now the DOJ have all declared illegitimate.
A System Already Declared Unconstitutional
In Axon Enterprise v. FTC (598 U.S. 175, 2023), the U.S. Supreme Court held that parties could bypass agency run tribunals and challenge their constitutionality in federal court. In SEC v. Jarkesy (2024), the Court went further, ruling that agency run Administrative Law Judge proceedings violate the Seventh Amendment's jury trial right, the nondelegation doctrine, and Article II's executive removal structure.
The legal writing is on the wall: these kangaroo courts must go.
The Department of Justice agrees.
DOJ Abandons Defense of DEA's ALJ System
In a historic filing on Fehttps://www.linkedin.com/feed/update/urn:li:ugcPost:7341266957737828352/ry 27, 2025, the DOJ notified the U.S. District Court in Rhode Island that it would no longer defend the DEA's ALJ system in MMJ BioPharma v. Bondi ([ECF 22](Case 1:24-cv-00127-WES-PAS)). Acting Solicitor General Sara Miron Bloom admitted the ALJ structure violates Article II's separation of powers. Citing Axon and Jarkesy, DOJ conceded that 5 U.S.C. § 7521 is unconstitutional and that DEA's internal judicial regime is legally indefensible.
Yet the DEA marches on in open defiance of the very government it is supposed to serve.
Mulrooney's Lawless Ruling
On June 16, 2025, DEA Chief ALJ John J. Mulrooney II-still clinging to a discredited position-issued a recommended denial of MMJ's bulk manufacturing application. No evidentiary hearing. No cross-examination. No valid record.
And no authority.
"This is bureaucratic mutiny," said MMJ's CEO Duane Boise. "The DOJ admits the system is illegal, yet the DEA keeps using it to punish medical marijuana research."
MMJ Fights Back on Two Fronts
Constitutional Lawsuit (DC Appeals Court)
MMJ's case against Attorney General Pam Bondi challenges the DEA's ALJ system outright. With DOJ's concession now on record, federal judges are poised to strike down the system altogether.DEA Administrative Appeal
On June 23, MMJ filed a Notice of Intent to File Exceptions (Docket No. 24-13) along with a motion requesting a 10-day extension. The basis? The complexity of the case and the suspicious holiday weekend deadline set by the DEA to limit MMJ's ability to respond.
"They're saying, 'Prove you drowned after we pushed you in the ocean,'" said MMJ CEO Duane Boise.
The Gaslighting and Hypocrisy Run Deep
Unlicensed Prosecutors: Lead DEA litigator Aarathi Haig is not licensed in New Jersey, violating federal ethics law (28 U.S.C. § 530B).
No Harm Argument: DOJ insists MMJ hasn't been harmed-while the DEA blocks it from trials, patients, and economic operations.
Shadow Justice: Mulrooney issued rulings from a court the DOJ abandoned-without any viable constitutional foundation.
"The DEA is a constitutional dead man walking," Boise declared. "Every day it uses this system, it digs its own grave deeper."
The Endgame: DEA's Administrative Empire Is Crumbling
Three outcomes are now in motion:
DEA ALJ System Will Be Dismantled: The DOJ won't defend it. SCOTUS already struck it down. Courts are next.
MMJ Will Prevail: The company is expected to succeed either administratively or judicially.
Congress Must Act: The DEA's shadow courts must be abolished. Cannabis oversight must shift to agencies like the FDA, where science-not sabotage-governs.
Justice Delayed Will No Longer Be Justice Denied
What began as a regulatory delay has become a constitutional crisis. The DEA has been caught running a rogue system, misusing authority, and subverting scientific advancement.
Now, the walls are closing in on Deputy Administrator Thomas Prevoznik, Matthew Strait, and Aarathi Haig.
MMJ is represented by attorney Megan Sheehan.
CONTACT:
Madison Hisey
[email protected]
203-231-8583
SOURCE: MMJ International Holdings
View the original press release on ACCESS Newswire
A.Moore--AT